Low dose radiation therapy attenuates ACE2 depression and inflammatory cytokines induction by COVID-19 viral spike protein in human bronchial epithelial cells

References

• Ameri A, Rahnama N, Bozorgmehr R, Mokhtari M, Farahbakhsh M, Nabavi M, Shoaei SD, Izadi H, Yousefi Kashi AS, Dehbaneh HS, et al. 2020. Low-dose whole-lung irradiation for COVID-19 pneumonia: short course results. Int J Radiat Oncol Biol Phys. 108(5):1134–1139.
   PubMed Web of Science ®Google Scholar
• Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, et al. 2020. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med. 383(25):2427–2438.
   PubMed Web of Science ®Google Scholar
• Arenas M, Sabater S, Hernández V, Rovirosa A, Lara PC, Biete A, Panés J. 2012. Anti-inflammatory effects of low-dose radiotherapy. Indications, dose, and radiobiological mechanisms involved. Strahlenther Onkol. 188(11):975–981.
   PubMed Web of Science ®Google Scholar
• Banaei A, Hashemi B, Bakhshandeh M. 2022. Estimating cancer risks due to whole lungs low dose radiotherapy with different techniques for treating COVID-19 pneumonia. Radiat Oncol. 17(1):10.
   PubMed Web of Science ®Google Scholar
• Calabrese EJ, Dhawan G. 2013. How radiotherapy was historically used to treat pneumonia: could it be useful today? Yale J Biol Med. 86:555–570.
   PubMedGoogle Scholar
• Cheng H, Wang Y, Wang GQ. 2020. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. J Med Virol. 92(7):726–730.
   PubMed Web of Science ®Google Scholar
• Copaescu A, Smibert O, Gibson A, Phillips EJ, Trubiano JA. 2020. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. J Allergy Clin Immunol. 146(3):518–534 e1.
   PubMed Web of Science ®Google Scholar
• Dhawan G, Kapoor R, Dhawan R, Singh R, Monga B, Giordano J, Calabrese EJ. 2020. Low dose radiation therapy as a potential life saving treatment for COVID-19-induced acute respiratory distress syndrome (ARDS). Radiother Oncol. 147:212–216.
   PubMed Web of Science ®Google Scholar
• Garcia-Hernandez T, Romero-Exposito M, Sanchez-Nieto B. 2020. Low dose radiation therapy for COVID-19: Effective dose and estimation of cancer risk. Radiother Oncol. 153:289–295.
   PubMed Web of Science ®Google Scholar
• Ghadimi-Moghadam A, Haghani M, Bevelacqua JJ, Jafarzadeh A, Kaveh-Ahangar A, Mortazavi SMJ, Ghadimi-Moghadam A, Mortazavi SAR. 2020. COVID-19 tragic pandemic: concerns over unintentional “directed accelerated evolution” of novel coronavirus (SARS-CoV-2) and introducing a modified treatment method for ARDS. J Biomed Phys Eng. 10:241.
   PubMedGoogle Scholar
• Glowacka I, Bertram S, Herzog P, Pfefferle S, Steffen I, Muench MO, Simmons G, Hofmann H, Kuri T, Weber F, et al. 2010. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. J Virol. 84(2):1198–1205.
   PubMed Web of Science ®Google Scholar
• Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus ADME, Timens W, Turner AJ, Navis G, van Goor H, et al. 2007. The emerging role of ACE2 in physiology and disease. J Pathol. 212(1):1–11.
   PubMed Web of Science ®Google Scholar
• Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. 2004. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 203(2):631–637.
   PubMed Web of Science ®Google Scholar
• Hess CB, Nasti TH, Dhere VR, Kleber TJ, Switchenko JM, Buchwald ZS, Stokes WA, Weinberg BD, Rouphael N, Steinberg JP, et al. 2021. Immunomodulatory low-dose whole-lung radiation for patients with coronavirus disease 2019-related pneumonia. Int J Radiat Oncol Biol Phys. 109(4):867–879.
   PubMed Web of Science ®Google Scholar
• Hess CB, Buchwald ZS, Stokes WA, Nasti T, Switchenko J, Weinberg BD, Rouphael N, Steinberg JP, Godette KD, Murphy DJ, et al. 2020. Immunomodulatory low-dose whole-lung radiation for patients with COVID-19-related pneumonia. Int J Radiat Oncol Biol Phys. 108(5):1401.
   PubMed Web of Science ®Google Scholar
• Hess CB, Buchwald ZS, Stokes W, Switchenko JM, Khan MK. 2020. Low-dose whole-lung radiation for COVID-19 pneumonia: planned day-7 interim analysis of a registered clinical trial. Cancer. 126:5109–5113.
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. 2020. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 181(2):271–280.e8.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, et al. 2005. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 436(7047):112–116.
   PubMed Web of Science ®Google Scholar
• Kefayat A, Ghahremani F. 2020. Low dose radiation therapy for COVID-19 pneumonia: a double-edged sword. Radiother Oncol. 147:224–225.
   PubMed Web of Science ®Google Scholar
• Khan MK, Hess CB. 2021. A call to action: “low-dose radiation may help cure COVID-19…” [Taps Mic] “…is this thing on?” JNCI Cancer Spectr. 5:pkaa105.
   PubMed Web of Science ®Google Scholar
• Kirkby C, Mackenzie M. 2020. Is low dose radiation therapy a potential treatment for COVID-19 pneumonia? Radiother Oncol. 147:221.
   PubMed Web of Science ®Google Scholar
• Kirsch DG. 2020. Radiation therapy as a treatment for COVID-19? Int J Radiat Oncol Biol Phys. 108:1140–1142.
   PubMedGoogle Scholar
• Krammer F. 2020. SARS-CoV-2 vaccines in development. Nature. 586(7830):516–527.
   PubMed Web of Science ®Google Scholar
• Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, et al. 2005. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 11(8):875–879.
   PubMed Web of Science ®Google Scholar
• Kuba K, Imai Y, Ohto-Nakanishi T, Penninger JM. 2010. Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther. 128(1):119–128.
   PubMed Web of Science ®Google Scholar
• Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, et al. 2020. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 382(13):1199–1207.
   PubMed Web of Science ®Google Scholar
• Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, et al. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 426(6965):450–454.
   PubMed Web of Science ®Google Scholar
• Liu X, Liu Z, Wang D, Han Y, Hu S, Xie Y, Liu Y, Zhu M, Guan H, Gu Y, et al. 2020. Effects of low dose radiation on immune cells subsets and cytokines in mice. Toxicol Res (Camb). 9(3):249–262.
   PubMed Web of Science ®Google Scholar
• Maqsudur Rashid A, Ramalingam L, Al-Jawadi A, Moustaid-Moussa N, Moussa H. 2019. Low dose radiation, inflammation, cancer and chemoprevention. Int J Radiat Biol. 95(4):506–515.
   PubMed Web of Science ®Google Scholar
• Deshotels MR, Xia H, Sriramula S, Lazartigues E, Filipeanu CM. 2014. Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor–dependent mechanism. Hypertension. 64(6):1368–1375.
   PubMed Web of Science ®Google Scholar
• Nicholls J, Peiris M. 2005. Good ACE, bad ACE do battle in lung injury, SARS. Nat Med. 11(8):821–822.
   PubMed Web of Science ®Google Scholar
• Ogunlade B, Guidry JJ, Lazartigues E, Filipeanu C. 2019. ACE2 internalization and degradation is controlled by ubiquitin ligase NEDD4. FASEB J. 33(S1):719.14–719.14.
   Google Scholar
• Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Mittal A. 2020. Repurposed antiviral drugs for Covid-19 — interim WHO solidarity trial results. New Eng J Med. 384:497–511.
   PubMed Web of Science ®Google Scholar
• Papachristofilou A, Finazzi T, Blum A, Zehnder T, Zellweger N, Lustenberger J, Bauer T, Dott C, Avcu Y, Kohler G. 2021. Low-dose radiation therapy for severe COVID-19 pneumonia: a randomized double-blind study. Int J Radiat Oncol Biol Phys. 110:1274–1282.
   PubMed Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Perez Marc G, Moreira ED, Zerbini C, et al. 2020. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 383(27):2603–2615.
   PubMed Web of Science ®Google Scholar
• Rodel F, Frey B, Gaipl U, Keilholz L, Fournier C, Manda K, Schollnberger H, Hildebrandt G, Rodel C. 2012. Modulation of inflammatory immune reactions by low-dose ionizing radiation: molecular mechanisms and clinical application. Curr Med Chem. 19(12):1741–1750.
   PubMed Web of Science ®Google Scholar
• Rodel F, Keilholz L, Herrmann M, Sauer R, Hildebrandt G. 2007. Radiobiological mechanisms in inflammatory diseases of low-dose radiation therapy. Int J Radiat Biol. 83(6):357–366.
   PubMed Web of Science ®Google Scholar
• Rodel F, Arenas M, Ott OJ, Fournier C, Georgakilas AG, Tapio S, Trott KR, Gaipl US. 2020. Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence? Strahlenther Onkol. 196(8):679–682.
   PubMed Web of Science ®Google Scholar
• Roedel F, Kley N, Beuscher HU, Hildebrandt G, Keilholz L, Kern P, Voll R, Herrmann M, Sauer R. 2002. Anti-inflammatory effect of low-dose X-irradiation and the involvement of a TGF-beta1-induced down-regulation of leukocyte/endothelial cell adhesion. Int J Radiat Biol. 78(8):711–719.
   PubMed Web of Science ®Google Scholar
• Sanmamed N, Alcantara P, Cerezo E, Gaztanaga M, Cabello N, Gomez S, Bustos A, Doval A, Corona J, Rodriguez G, et al. 2021. Low-dose radiation therapy in the management of coronavirus disease 2019 (COVID-19) pneumonia (LOWRAD-Cov19): preliminary report. Int J Radiat Oncol Biol Phys. 109(4):880–885.
   PubMed Web of Science ®Google Scholar
• Tripathy AS, Vishwakarma S, Trimbake D, Gurav YK, Potdar VA, Mokashi ND, Patsute SD, Kaushal H, Choudhary ML, Tilekar BN, et al. 2021. Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection . Arch Virol. 166(12):3301–3310.
   PubMed Web of Science ®Google Scholar
• Wang G, Zhao Q, Zhang H, Liang F, Zhang C, Wang J, Chen Z, Wu R, Yu H, Sun B, et al. 2021. Degradation of SARS-CoV-2 receptor ACE2 by the E3 ubiquitin ligase Skp2 in lung epithelial cells. Front Med. 15(2):252–263.
   PubMed Web of Science ®Google Scholar
• Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. 2020. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 367(6483):1260–1263.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. 2020a. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L, et al. 2020b. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 579(7798):270–273.
   PubMed Web of Science ®Google Scholar
• Zou X, Chen K, Zou J, Han P, Hao J, Han Z. 2020. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 14(2):185–192.
   PubMed Web of Science ®Google Scholar